A phase III trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate- or high-risk endometrial cancer. ENGOT-EN2-DGCG/EORTC 55102.
Mansoor Raza Mirza
No relevant relationships to disclose
Caroline Lundgren
No relevant relationships to disclose
Frederic Kridelka
No relevant relationships to disclose
Annamaria Ferrero
No relevant relationships to disclose
Frederic Amant
No relevant relationships to disclose